Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrosis progression in chronic hepatitis C virus infection.

Literature DB >> 14960506

Fibrosis progression in chronic hepatitis C virus infection.

Abstract

Chronic hepatitis C virus infection is typically characterised by slowly progressive hepatic fibrosis. However, it is recognised that some patients do not progress while others rapidly develop significant fibrosis. Here, we review studies that have assessed factors that could influence this rate of fibrotic progression.

Entities: Disease Species

Mesh：

Year: 2004 PMID： 14960506 PMCID： PMC1773949 DOI： 10.1136/gut.2003.026393

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

34 in total

Review 1. Interactions between hepatic stellate cells and the immune system.

Authors: J J Maher
Journal: Semin Liver Dis Date: 2001-08 Impact factor: 6.115

2. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.

Authors: Georgina Paizis; Mark E Cooper; Josefa M Schembri; Christos Tikellis; Louise M Burrell; Peter W Angus
Journal: Gastroenterology Date: 2002-11 Impact factor: 22.682

Review 3. Fibrosis and disease progression in hepatitis C.

Authors: Patrick Marcellin; Tarik Asselah; Nathalie Boyer
Journal: Hepatology Date: 2002-11 Impact factor: 17.425

4. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors: L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal: Hepatology Date: 2001-06 Impact factor: 17.425

5. Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.

Authors: H Fontaine; B Nalpas; B Poulet; F Carnot; H Zylberberg; C Brechot; S Pol
Journal: Hum Pathol Date: 2001-09 Impact factor: 3.466

6. Progression of fibrosis in untreated patients with hepatitis C virus infection.

Authors: L Martin Lagging; Johan Westin; Elisabeth Svensson; Nibia Aires; Amar P Dhillon; Magnus Lindh; Rune Wejstål; Gunnar Norkrans
Journal: Liver Date: 2002-04

Review 7. Cytokines and chemokines in the immune response to hepatitis C infection.

Authors: M Heydtmann; P Shields; G McCaughan; D Adams
Journal: Curr Opin Infect Dis Date: 2001-06 Impact factor: 4.915

8. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Authors: Jason M Hui; James Kench; Geoffrey C Farrell; Rita Lin; Dev Samarasinghe; Christopher Liddle; Karen Byth; Jacob George
Journal: J Gastroenterol Hepatol Date: 2002-08 Impact factor: 4.029

9. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.

Authors: Laura Sonzogni; Laura Silvestri; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Riccardo Bottelli; Mario U Mondelli; Emilio Civardi; Enrico M Silini
Journal: Hepatology Date: 2002-07 Impact factor: 17.425

10. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.

Authors: Dinesh Kumar; Geoffrey C Farrell; Caroline Fung; Jacob George
Journal: Hepatology Date: 2002-11 Impact factor: 17.425

24 in total

1. Predicting the probable outcome of treatment in HCV patients.

Authors: Udayakumar Navaneethan; Nyingi Kemmer; Guy W Neff
Journal: Therap Adv Gastroenterol Date: 2009-09 Impact factor: 4.409

2. Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.

Authors: Ali Afsari; Edward Lee; Babak Shokrani; Tina Boortalary; Zaki A Sherif; Mehdi Nouraie; Adeyinka O Laiyemo; Kawtar Alkhalloufi; Hassan Brim; Hassan Ashktorab
Journal: Dig Dis Sci Date: 2017-06-13 Impact factor: 3.199

Review 3. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors: Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal: World J Hepatol Date: 2013-10-27

4. Effects of the dihydrolipoyl histidinate zinc complex against carbon tetrachloride-induced hepatic fibrosis in rats.

Authors: Yuichiro Kawano; Masayuki Ohta; Yukio Iwashita; Yoko Komori; Masafumi Inomata; Seigo Kitano
Journal: Surg Today Date: 2014-09 Impact factor: 2.549

Review 5. Steatosis in chronic hepatitis C: why does it really matter?

Authors: T Asselah; L Rubbia-Brandt; P Marcellin; F Negro
Journal: Gut Date: 2006-01 Impact factor: 23.059

Review 6. Insulin resistance and steatosis in hepatitis C virus infection.

Authors: A Zekry; J G McHutchison; A M Diehl
Journal: Gut Date: 2005-07 Impact factor: 23.059

7. Hepatitis C virus infection and nonalcoholic steatohepatitis.

Authors: Anish Patel; Stephen A Harrison
Journal: Gastroenterol Hepatol (N Y) Date: 2012-05

8. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.

Authors: Annie-Carole Tosello-Trampont; Susan G Landes; Virginia Nguyen; Tatiana I Novobrantseva; Young S Hahn
Journal: J Biol Chem Date: 2012-10-12 Impact factor: 5.157

9. Hepatitis C virus induces the cannabinoid receptor 1.

Authors: David van der Poorten; Mahsa Shahidi; Enoch Tay; Jayshree Sesha; Kayla Tran; Duncan McLeod; Jane S Milliken; Vikki Ho; Lionel W Hebbard; Mark W Douglas; Jacob George
Journal: PLoS One Date: 2010-09-17 Impact factor: 3.240

Review 10. Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.

Authors: Suhag Patel; Raxitkumar Jinjuvadia; Ravi Patel; Suthat Liangpunsakul
Journal: J Clin Gastroenterol Date: 2016-01 Impact factor: 3.062